Acerand Therapeutics
PrivateCompany Overview
Acerand Therapeutics is a biotechnology company that focuses on the discovery and development of novel small-molecule drug candidates for the treatment of oncology, immunology, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acerand Therapeutics Comparables
Compare Acerand Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synnovation Therapeutics | 88% | |
| Duke Street Bio | 81% | |
| Tilikum Therapeutics | 81% | |
Acerand Therapeutics Funding Rounds
Historical fundraising activity
Acerand Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lilly Asia Ventures | Seed |
Acerand Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Acerand Therapeutics's valuation, stock price, and market status.